TY - JOUR
T1 - Control of adipose tissue inflammation through TRB1
AU - Ostertag, Anke
AU - Jones, Allan
AU - Rose, Adam J.
AU - Liebert, Maria
AU - Kleinsorg, Stefan
AU - Reimann, Anja
AU - Vegiopoulos, Alexandros
AU - Diaz, Mauricio Berriel
AU - Strzoda, Daniela
AU - Yamamoto, Masahiro
AU - Satoh, Takashi
AU - Akira, Shizuo
AU - Herzig, Stephan
PY - 2010/8
Y1 - 2010/8
N2 - OBJECTIVE - Based on its role as an energy storage compartment and endocrine organ, white adipose tissue (WAT) fulfills a critical function in the maintenance of whole-body energy homeostasis. Indeed, WAT dysfunction is connected to obesity-related type 2 diabetes triggered at least partly by an inflammatory response in adipocytes. The pseudokinase tribbles (TRB) 3 has been identified by us and others as a critical regulator of hepatic glucose homeostasis in type 2 diabetes and WAT lipid homeostasis. Therefore, this study aimed to test the hypothesis that the TRB gene family fulfills broader functions in the integration of metabolic and inflammatory pathways in various tissues. RESEARCH DESIGN AND METHODS - To determine the role of TRB family members for WAT function, we profiled the expression patterns of TRB13 under healthy and metabolic stress conditions. The differentially expressed TRB1 was functionally characterized in loss-of-function animal and primary adipocyte models. RESULTS - Here, we show that the expression of TRB1 was specifically upregulated during acute and chronic inflammation in WAT of mice. Deficiency of TRB1 was found to impair cytokine gene expression in white adipocytes and to protect against high-fat diet-induced obesity. In adipocytes, TRB1 served as a nuclear transcriptional coactivator for the nuclear factor κB subunit RelA, thereby promoting the induction of proinflammatory cytokines in these cells. CONCLUSIONS - As inflammation is typically seen in sepsis, insulin resistance, and obesity-related type 2 diabetes, the dual role of TRB1 as both a target and a (co) activator of inflammatory signaling might provide a molecular rationale for the amplification of proinflammatory responses in WAT in these subjects.
AB - OBJECTIVE - Based on its role as an energy storage compartment and endocrine organ, white adipose tissue (WAT) fulfills a critical function in the maintenance of whole-body energy homeostasis. Indeed, WAT dysfunction is connected to obesity-related type 2 diabetes triggered at least partly by an inflammatory response in adipocytes. The pseudokinase tribbles (TRB) 3 has been identified by us and others as a critical regulator of hepatic glucose homeostasis in type 2 diabetes and WAT lipid homeostasis. Therefore, this study aimed to test the hypothesis that the TRB gene family fulfills broader functions in the integration of metabolic and inflammatory pathways in various tissues. RESEARCH DESIGN AND METHODS - To determine the role of TRB family members for WAT function, we profiled the expression patterns of TRB13 under healthy and metabolic stress conditions. The differentially expressed TRB1 was functionally characterized in loss-of-function animal and primary adipocyte models. RESULTS - Here, we show that the expression of TRB1 was specifically upregulated during acute and chronic inflammation in WAT of mice. Deficiency of TRB1 was found to impair cytokine gene expression in white adipocytes and to protect against high-fat diet-induced obesity. In adipocytes, TRB1 served as a nuclear transcriptional coactivator for the nuclear factor κB subunit RelA, thereby promoting the induction of proinflammatory cytokines in these cells. CONCLUSIONS - As inflammation is typically seen in sepsis, insulin resistance, and obesity-related type 2 diabetes, the dual role of TRB1 as both a target and a (co) activator of inflammatory signaling might provide a molecular rationale for the amplification of proinflammatory responses in WAT in these subjects.
UR - http://www.scopus.com/inward/record.url?scp=77955356238&partnerID=8YFLogxK
U2 - 10.2337/db09-1537
DO - 10.2337/db09-1537
M3 - Article
C2 - 20522600
AN - SCOPUS:77955356238
SN - 0012-1797
VL - 59
SP - 1991
EP - 2000
JO - Diabetes
JF - Diabetes
IS - 8
ER -